Barone Samuel B.
Insider CIK 1614995 · AAVL SVP, Clinical Development · GMTX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GMTX Gemini Therapeutics, Inc. | A Award deriv | 2021-04-12 | 2021-04-14 | 255,212 | — | $0 | 255,212 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2017-02-09 | 2017-02-13 | 84,000 | — | $0 | 84,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2017-02-09 | 2017-02-13 | 58,000 | — | $0 | 172,335 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award deriv | 2016-06-17 | 2016-06-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ADVM Adverum Biotechnologies, I | A Award | 2016-06-17 | 2016-06-21 | 20,000 | — | $0 | 114,335 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2016-02-12 | 2016-02-17 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2016-02-12 | 2016-02-17 | 50,000 | — | $0 | 91,603 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2015-08-21 | 2015-08-25 | 33,960 | — | $0 | 40,960 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award deriv | 2015-04-21 | 2015-04-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| AAVL Avalanche Biotechnologies, | A Award | 2015-04-21 | 2015-04-23 | 7,000 | — | $0 | 7,000 | SEC↗ |